Literature DB >> 33522706

Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.

Timothy N Rogers1, Guido Seitz2, Jörg Fuchs3, Helene Martelli4, Roshni Dasgupta5, Jonathan C Routh6, Douglas S Hawkins7, Ewa Koscielniak8, Gianni Bisogno9, David A Rodeberg10.   

Abstract

The treatment of paratesticular rhabdomyosarcoma (PT-RMS) has varied over time and by cooperative group. The International Soft Tissue Sarcoma Database Consortium (INSTRuCT) is a collaboration of the Children's Oncology Group (COG) Soft Tissue Sarcoma Committee, European pediatric Soft tissue sarcoma Study Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS). The INSTRuCT surgical committee has been given charge of the development of internationally applicable consensus guidelines for the surgical treatment of rhabdomyosarcoma. This clinical consensus opinion document addresses accepted principles and areas of controversy, such as scrotal violation and retroperitoneal nodal evaluation, providing an evidence-based guideline for the surgical treatment for PT-RMS.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  international; paratesticular; pediatric; rhabdomyosarcoma

Mesh：

Year:  2021        PMID： 33522706      PMCID： PMC9019908          DOI： 10.1002/pbc.28938

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.838


  46 in total

1.  Paratesticular rhabdomyosarcoma: Importance of initial therapy.

Authors:  William J Hammond; Benjamin A Farber; Anita P Price; Suzanne L Wolden; Todd E Heaton; Leonard H Wexler; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2016-11-14       Impact factor: 2.545

2.  Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  R Beverly Raney; David O Walterhouse; Jane L Meza; Richard J Andrassy; John C Breneman; William M Crist; Harold M Maurer; William H Meyer; David M Parham; James R Anderson
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

3.  Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.

Authors:  Richard J Stewart; Hélène Martelli; Odile Oberlin; Annie Rey; Nathalie Bouvet; Richard D Spicer; Jan Godzinski; Michael C G Stevens
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

4.  Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma.

Authors:  E S Wiener; W Lawrence; D Hays; T E Lobe; R Andrassy; S Donaldson; W Crist; W Newton; J Johnson; E Gehan
Journal:  J Pediatr Surg       Date:  1994-02       Impact factor: 2.545

5.  Temporary relocation of testes to the anterior abdominal wall before radiation therapy of the pelvis or perineum.

Authors:  Juan M Acosta; Greg Tiao; James E Stein; G Hossein Mahour
Journal:  J Pediatr Surg       Date:  2002-08       Impact factor: 2.545

6.  Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.

Authors:  Guido Seitz; Jörg Fuchs; Peter Martus; Thomas Klingebiel; Ivo Leuschner; Andreas Schuck; Tobias M Dantonello; Ewa Koscielniak
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

7.  Surgical repositioning of the contralateral testicle before irradiation of a paratesticular rhabdomyosarcoma for preservation of hormone production.

Authors:  Kathleen Grüschow; Ulrike Kyank; Gerhard Stuhldreier; Rainer Fietkau
Journal:  Pediatr Hematol Oncol       Date:  2007 Jul-Aug       Impact factor: 1.969

8.  Robotic retroperitoneal paraaortic lymphadenectomy at Donostia University Hospital.

Authors:  Mikel Gorostidi; Joana Larreategui; Teresa Bernal; Constance Goiri; Miren Arrue; Pepe Navarrina; Arantxa Lekuona
Journal:  J Minim Invasive Gynecol       Date:  2013-10-22       Impact factor: 4.137

9.  Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG).

Authors:  Timothy N Rogers; Federica De Corti; Gabriela Guillén Burrieza; Florent Guérin; Sheila Terwisscha van Scheltinga; Naima Smeulders; Ross Craigie; Meriel Jenney; Anna Kelsey; Ilaria Zanetti; Beatrice Coppadoro; Gian Luca De Salvo; Gianni Bisogno; Hélène Martelli
Journal:  Pediatr Blood Cancer       Date:  2020-06-23       Impact factor: 3.167

Review 10.  Laparoscopic retroperitoneal lymph node dissection for testicular cancer.

Authors:  Joel H Hillelsohn; Brian D Duty; Zhamshid Okhunov; Louis R Kavoussi
Journal:  Arab J Urol       Date:  2012-02-14
View more
  5 in total

1.  Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).

Authors:  Kirk D Wyatt; Suzi Birz; Douglas S Hawkins; Veronique Minard-Colin; David A Rodeberg; Monika Sparber-Sauer; Gianni Bisogno; Ewa Koscielniak; Gian Luca De Salvo; Martin Ebinger; Johannes H M Merks; Suzanne L Wolden; Wei Xue; Samuel L Volchenboum
Journal:  Pediatr Blood Cancer       Date:  2022-08-15       Impact factor: 3.838

2.  [Clinical features and prognosis in 20 children with rhabdomyosarcoma].

Authors:  Si-Qin Liu; Fang-Hua Ye; Chen-Ying Fan; Min Peng; Jia-Jia Dong; Wen-Jun Deng; Hui Zhang; Yan Yu; Liang-Chun Yang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022 Sept 15

Review 3.  Optimizing Rhabdomyosarcoma Treatment in Adolescents and Young Adults.

Authors:  Atsushi Makimoto
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

Review 4.  Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.

Authors:  Jacquelyn N Crane; Wei Xue; Amira Qumseya; Zhengya Gao; Carola A S Arndt; Sarah S Donaldson; Douglas J Harrison; Douglas S Hawkins; Corinne M Linardic; Leo Mascarenhas; William H Meyer; David A Rodeberg; Erin R Rudzinski; Barry L Shulkin; David O Walterhouse; Rajkumar Venkatramani; Aaron R Weiss
Journal:  Pediatr Blood Cancer       Date:  2022-03-06       Impact factor: 3.838

Review 5.  Radioresistance in rhabdomyosarcomas: Much more than a question of dose.

Authors:  Simona Camero; Matteo Cassandri; Silvia Pomella; Luisa Milazzo; Francesca Vulcano; Antonella Porrazzo; Giovanni Barillari; Cinzia Marchese; Silvia Codenotti; Miriam Tomaciello; Rossella Rota; Alessandro Fanzani; Francesca Megiorni; Francesco Marampon
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.